Effect of 3-methylcholanthrene pretreatment on the bioavailability of phenacetin in the rat
- PMID: 8296
Effect of 3-methylcholanthrene pretreatment on the bioavailability of phenacetin in the rat
Abstract
A thin-layer chromatographic procedure is described for the quantitative determination of phenacetin and acetaminophen in rat plasma. The method was used to determine the effect of 3-methylcholanthrene (3-MC) on the disposition and bioavailability of phenacetin following its oral and iv administration to rats. Pretreatment with 3-MC decreased the plasma half-life of phenacetin, after iv administration, from 28 min to 4.5 min and reduced the systemic bioavailability of phenacetin, after oral administration, from 45% in control rats to 6% in 3-MC-treated rats. By comparing the plasma levels of phenacetin in the portal circulation with those in the peripheral circulation, following the oral administration of phenacetin, it was concluded that the 7-fold reduction in the bioavailability of phenacetin observed in 3-MC treated rats was caused by a marked increase in the metabolism of phenacetin during its first pass through the liver.
Similar articles
-
In vivo O-de-ethylation of phenacetin in 3-methylcholanthrene-pretreated rats: gut wall and liver first-pass metabolism.J Pharmacol Exp Ther. 1983 Apr;225(1):153-7. J Pharmacol Exp Ther. 1983. PMID: 6834267
-
Effect of an experimental malaria infection on the metabolism of phenacetin in the rat isolated perfused liver.Xenobiotica. 1994 Aug;24(8):785-93. doi: 10.3109/00498259409043278. Xenobiotica. 1994. PMID: 7839701
-
The 3-methylcholanthrene-mimetic effect of 4,4'-dichlorobiphenyl-treatment on phenacetin-induced hepatic glutathione depletion and liver microsomal phenacetin O-deethylation in rats.Toxicology. 1986 Dec 15;42(2-3):259-74. doi: 10.1016/0300-483x(86)90014-4. Toxicology. 1986. PMID: 3099430
-
Role of the hepatic artery in the metabolism of phenacetin and acetaminophen: intravital microscopic and multiple-indicator dilution study in perfused rat liver.Hepatology. 1994 Sep;20(3):672-83. Hepatology. 1994. PMID: 8076925
-
The metabolism of acetophenetidin and N-acetyl-p-aminophenol in the cat.Biochem Pharmacol. 1966 May;15(5):521-31. doi: 10.1016/0006-2952(66)90018-9. Biochem Pharmacol. 1966. PMID: 5961431 No abstract available.
Cited by
-
Modulation of Rat Hepatic CYP1A and 2C Activity by Honokiol and Magnolol: Differential Effects on Phenacetin and Diclofenac Pharmacokinetics In Vivo.Molecules. 2018 Jun 17;23(6):1470. doi: 10.3390/molecules23061470. Molecules. 2018. PMID: 29914211 Free PMC article.
-
Role of tobacco smoking in pharmacokinetics.J Pharmacokinet Biopharm. 1978 Feb;6(1):7-39. doi: 10.1007/BF01066061. J Pharmacokinet Biopharm. 1978. PMID: 349132 Review. No abstract available.
-
Theoretical considerations on two equations for estimating the extent of absorption after oral administration of drugs.Pharm Res. 1996 Apr;13(4):566-9. doi: 10.1023/a:1016046004945. Pharm Res. 1996. PMID: 8710747
-
Influence of age and smoking on drug kinetics in man: studies using model compounds.Clin Pharmacokinet. 1980 Jul-Aug;5(4):309-19. doi: 10.2165/00003088-198005040-00001. Clin Pharmacokinet. 1980. PMID: 6994978 Review.
-
Application of Physiologically Based Pharmacokinetic Modeling in Preclinical Studies: A Feasible Strategy to Practice the Principles of 3Rs.Front Pharmacol. 2022 May 12;13:895556. doi: 10.3389/fphar.2022.895556. eCollection 2022. Front Pharmacol. 2022. PMID: 35645843 Free PMC article.